Home›Screener›BEAM›Profile
B
71/100

Beam Therapeutics

BEAMBase Editing
← Signals View
📋
Analyst Summary
✓ VERIFIED2026-04-11

Beam Therapeutics (BEAM) is the lead sponsor of 6 active clinical trials listed on ClinicalTrials.gov[3], including 4 Phase 2[1], 5 Phase 1[2].

BEAM has 11 Form 4 insider filings recorded at the SEC in the past 30 days[4].

Sources

  1. ClinicalTrials.gov (2026-04-11) ↗
  2. ClinicalTrials.gov (2026-04-11) ↗
  3. ClinicalTrials.gov (2026-04-11) ↗
  4. SEC EDGAR · 0001745999 (2026-04-11) ↗
🏛
Upcoming Catalysts
BEAM-101 — sickle cell disease
2026-06-15
in 11d
🔬
Clinical Trials
6
NCT05456880Sickle Cell Disease
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05885464Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06389877Alpha 1-Antitrypsin Deficiency
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06735755Glycogen Storage Disease Type Ia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07304791Healthy Subjects, Healthy Participant Study
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07373639Hemoglobinopathy, Sickle Cell Disease
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
👤
Insider Activity
1
11 filings
Source ↗
sec_edgar · Retrieved 2026-04-11
Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-132026-06-02
Signal Summary
PDUFA Dates1
Insider Filings1
Clinical Trials5
Data Provenance
cik1 verified
clinical trial6 verified
insider buy1 verified
trial count3 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR